Vascular Research Initiatives Conference (VRIC) 2022

Location: Sheraton Grand Seattle Hotel 1400 6th Ave, Seattle, WA
Sponsored by: SVS

The Vascular Research Initiatives Conference (VRIC) emphasizes the exchange of basic and translational vascular science that stimulates thoughtful discussion and motivates participants to discover solutions to important problems affecting vascular patients. The VRIC brings together vascular surgeons, vascular biologists, physicians with an interest in vascular problems, vascular surgery trainees and research trainees in vascular surgery and vascular biology. 

VRIC 2022, with the theme "Translational Immunology and Cardiovascular Disease," will take place the day before the American Heart Association's Vascular Discovery 2022 Conference in Seattle, Washington (May 12-14). 

Registration for this event is now closed.

Agenda

Access the full conference agenda here.

Accreditation Information

Date: May 11, 2022
Last Day to Claim CME: June 30, 2022
Max AMA PRA Category 1 Credits :  5.50

By participating in this CME activity, the learner will be able to:

  1. Enhance research techniques and clinical trials. 
  2. Utilize a multidisciplinary approach to patient management based on clinical studies & guidelines.
  3. Apply current standards of care in the management of vascular patients.

This CE Activity is supported through an educational grant provided by Gore and Boston Scientific.

Accreditation Statement

The Society for Vascular Surgery is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Society for Vascular Surgery designates this live course for a maximum of 5.50 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement

The ACCME requires that the SVS, as an accredited provider of CME, disclose the relevant financial relationships of the planners, faculty, and any other individuals in a position to control content of this activity. If there is a relevant financial relationship that has been disclosed, please find it below:

Name of Individual Company/Organization Nature of Financial Relationship(s)
Mohamed Zayed, MD, PhD, FACS
  • Cardiovascular Systems, Inc
  • Caeli Vascular, Inc
  • Consultant
  • CMO
Jean Marie Ruddy, MD FACS
  • CVRx
  • Surgical Proctor
Caitlin W. Hicks MD, MS
  • W. L. Gore
  • Cook Medical
  • NIH/NIDDK
  • American College of Surgeons
  • Society for Vascular Surgery
  • Speaker
  • Speaker
  • Grant
  • Grant
  • Grant
Andrea Obi, MD
  • Medtronic
  • Priniciple Investigator
Iraklis I. Pipinos, MD
  • Novo Nordisk A/S
  • MitoO
  • MitoO
     
  • Investigator in the trial STRIDE
  • Investigator in a trial currently being planned
  • Investigator in a completed trial
Elsie Ross, MD
  • W. L. Gore Medical
  • Consultant
Jason MacTaggart, MD
  • Vessel Wave Technologies
  • Aquablade 
  • Founder, stock ownership, licensed IP
  • Founder, stock ownership, licensed IP
Nicholas Osborne, MD
  • Medtronic Aortic
  • Consultant
George J Arnaoutakis
  • Terumo Aortic
  • Consultant
Michael S Conte, MD
  • Profusa Inc.
  • Abbott Vascular
  • Independent Contractor (including contracted research)
  • DSMB member
Scott M. Damrauer, MD
  • RenalytixAI
  • Calico Labs
  • Research support to institution
  • Consultant
Michael Holinstat
  • Veralox Therapeutics
  • Cereno Scientific
  • Consultant
  • Consultant
Hanjoong Jo, PhD
  • FloKines Pharma
  • Employee/executive/owner (of a pharmaceutical or medical device manufacturer)
Katalin Kauser MD PhD DSc
  • Alucent Biomedical, Inc
  • Employee/executive/owner (of a pharmaceutical or medical device manufacturer)
Jason S. Knight, MD, PhD
  • Jazz Pharmaceuticals
  • Research Grant
Nicholas J. Leeper
  • Bitterroot Bio
  • Co-Founder, director, and consultant
Kaspars Maleckis, Ph.D.
  • Qmedics AG
  • Independent Contractor (including contracted research)
Sara A. Myers, PhD
  • Elvee Performance Technologies, LLC
  • ATG
  • Employee/executive/owner (of a pharmaceutical or medical device manufacturer)
  • Consultant
Clay F Semenkovich M
  • Alnylam
  • Consultant
Qizhi Tang, PhD
  • Sonoma Biotherapeutics
  • Encellin
  • eGenesis
  • Qihan Bio
  • Minutia
  • co-founder, share holder, advisor, and research grant
  • Individual stocks and stock options that are not diversified mutual funds
  • Individual stocks and stock options that are not diversified mutual funds
  • Advisor
  • Individual stocks and stock options that are not diversified mutual funds
     
Shant M. Vartanian, MD
  • Surmondics
  • Consultant
Kerstin Rebrin, MD, PhD
  • Profusa, Inc.
  • Employee/executive/owner (of a pharmaceutical or medical device manufacturer)
Peter A. Schneider, MD
  • Surmodics
  • Silk Road Medical
  • Cagent
  • LimFlow
  • Philips
  • Medtronic
  • CSI
  • Consultant
  • Consultant
  • Consultant
  • Consultant
  • Consultant
  • Consultant
  • Consultant

All other individuals in control of content have indicated that there are no relevant financial relationships with ineligible companies to be disclosed. All relevant financial relationships have been mitigated.

Additional Information About VRIC

New and evolving topics may be discussed, debated, and explored during the VRIC. Planners and faculty must facilitate engagement with these topics without advocating for or promoting practices that are not or not yet adequately based on current science, evidence, and clinical reasoning.

As a condition of its ACCME Accreditation, SVS’s CE activities will not advocate for unscientific approaches to diagnosis or therapy, or promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
 

VRIC 2022 Premier Speakers

Lecture Speaker Talk Title

Alexander W. Clowes Distinguished Lecture

The lecture is named for the late SVS member Alec Clowes, a renowned mentor and surgeon-scientist who demonstrated an exceptional commitment to research in vascular disease and played a critical role in VRIC.

Kathleen Martin, PhD Epigenetic Regulation of Vascular Smooth Muscle Plasticity

Translational Panel

Katey Rayner, PhD, FAHA Cholesterol, Inflammation and Atherosclerosis: Expecting the Unexpected
Translational Panel Nicholas Leeper, MD Bench-to-bedside translation of pro-efferocytic therapies

Health & Safety Protocols

We are delighted to welcome our VRIC attendees, staff and guests to Seattle for VRIC 2022.  The health and safety of our members and guests are of primary importance.  We have been monitoring the current situation with COVID-19, and are taking measures to support compliance with Center for Disease Control and King County guidelines.

At a minimum, you can expect the following health and safety protocols to be in place: 

Proof of Vaccination/Negative COVID test (within 72 hours of travel). All attendees and staff will be required to provide proof of vaccination OR negative COVID test taken within 72 hours of arrival date in Seattle.  All individuals will need to present documentation at the on-site registration, just outside the session room, prior to being issued an official meeting badge.

Masks: Masks will be optional for this event.
More Information:

SVS will communicate any changes to this information as it becomes available. Looking forward to seeing everyone in Seattle!

COVID-19 Waiver

All registrants must complete an online COVID-19 release and waiver as part of registration. To review the waiver ahead of time, please click here. 

 

Attendee Housing

Attendees can now make reservations at the Sheraton Grand Seattle Hotel for VRIC 2022 either online or by phone.

Online reservations will be made through the Vascular Discovery Conference hotel portal. Please note:

  • If booking by phone, you must mention you are booking as part of the AHA’s Vascular Discovery room block to get the discounted rate of $199/night + taxes/fees. 

SHERATON GRAND SEATTLE HOTEL
1400 6th Avenue
Seattle, Washington 98101
Main Hotel Phone: +1 206-621-9000
Toll-Free Reservations: +1 888-627-7056

The rate is available on a first-come, first-served basis. After April 18 reservations will be accepted at the group rate, if rooms are still available. The group rate will be honored 3 days before and after the Vascular Discover meeting (May 12-14). 


Questions

Please email the SVS Education Department.

Upcoming Meetings